This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Rodolfo Montironi: Innovator in Cancer Prediction Technology
Introduction
Rodolfo Montironi is a notable inventor based in Corinaldo, Italy. He has made significant contributions to the field of medical technology, particularly in cancer prediction. His innovative approach combines biological analysis with advanced computational techniques to enhance patient outcomes.
Latest Patents
Montironi holds a patent for a "Karyometry-based method for prediction of cancer event recurrence." This method involves scanning a biological tissue sample to produce an image and corresponding optical-density data. A computerized algorithm is employed to identify and segregate nuclei within the image. The optical density values related to nuclear chromatin are analyzed to identify numerical patterns that hold statistical significance concerning the health condition of the biological tissue. These patterns are further examined through discriminant analysis and a non-supervised learning algorithm to predict changes that may indicate a risk for the recurrence of a cancer event, such as a malignant lesion. He has 1 patent to his name.
Career Highlights
Throughout his career, Montironi has focused on integrating technology with biological research. His work has been pivotal in advancing methods for cancer prediction, which can lead to timely interventions and improved patient care. His dedication to innovation in this field has established him as a respected figure among his peers.
Collaborations
Montironi collaborates with various professionals in the medical and technological fields. One of his notable coworkers is Peter H Bartels, with whom he shares insights and expertise to further enhance their research and development efforts.
Conclusion
Rodolfo Montironi's contributions to cancer prediction technology exemplify the intersection of innovation and healthcare. His patented methods have the potential to significantly impact patient outcomes and advance the field of medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile